MagPortal.com   Clustify - document clustering
 Home  |  Newsletter  |  My Articles  |  My Account  |  Help 
Similar Articles
The Motley Fool
May 12, 2004
Charly Travers
Cubist Addresses a Niche Market This small firm is developing antibiotics to meet a medical need. mark for My Articles similar articles
BusinessWeek
April 12, 2004
Catherine Arnst
Killer Staph Is Hitting The Streets For the past 30 years, hospitals have been battling a mutant form called methicillin-resistant S. aureus (MRSA) that is resistant to penicillin-related antibiotics and is especially lethal. Now it's showing up in the general population. mark for My Articles similar articles
AskMen.com
Harold Russell
The Lowdown On Superbugs The overuse and misuse of antibiotics has led to the development of resistant strains of bacteria, commonly referred to as superbugs. mark for My Articles similar articles
Pharmaceutical Executive
October 1, 2008
Michael Bonney
Specialty Sales Gets No Resistance The author, a Cubist Pharmaceuticals CEO. has given his company a successful start and is now predicting the future of drug resistance. mark for My Articles similar articles
The Motley Fool
March 25, 2009
Brian Orelli
Wyeth: Now Approved to Kill More Bugs! Wyeth's antibiotic gets approved for another indication. mark for My Articles similar articles
The Motley Fool
April 8, 2005
Brian Gorman
Cubist in Neutral Cubist Pharmaceuticals' pipeline may be why investors are unimpressed. mark for My Articles similar articles
The Motley Fool
June 28, 2005
Charly Travers
Growth Around the Corner? Despite a thin pipeline, small biotech Cubist Pharmaceuticals is hoping to ride the wave of prosperity. Investors, take note. mark for My Articles similar articles
Health
June 19, 2009
Ginny Graves
How to Combat the Latest Supergerms While some germs may be outpacing our ability to kill them, we're not completely defenseless. In fact, there are plenty of things we can do to slow their spread. mark for My Articles similar articles
Chemistry World
August 11, 2014
Phillip Broadwith
Single shot antibiotic approved for skin infections Intravenous antibiotic Orbactiv oritavancin, from US firm The Medicines Company, has been approved by the US Food and Drug Administration. mark for My Articles similar articles
Chemistry World
February 12, 2015
Dinsa Sachan
Target ignorance to tackle resistance After the discovery of the New Delhi metallo-beta-lactamase-1 (NDM-1) gene, which renders some bacteria resistant to most antibiotics, India has attracted global criticism for not being able to contain antibiotic resistance. mark for My Articles similar articles
Scientific American
January 2007
Meet Resistance Head-On With resistance to antibiotics growing at an alarming pace among pathogenic bacteria, Americans must become more aggressive with regard to early intervention in the processes that foster resistance. mark for My Articles similar articles
Nutrition Action Healthletter
May 2000
Magic Bullets Under Siege ...Antibiotics---drugs that kill bacteria---account for much of our success in the war against infectious illness. But the miracle drugs of medicine are in danger... mark for My Articles similar articles
American Family Physician
January 15, 2004
Antibiotics: When They Can and Can't Help What are antibiotics?... Do antibiotics work against all infections?... What is "antibiotic resistance"?... Why should I worry about antibiotic resistance?... How do I know when I need antibiotics?... How should I take the antibiotics that my doctor prescribes?... etc. mark for My Articles similar articles
American Family Physician
September 15, 2006
When Antibiotics Can Help A consumer's guide: What are antibiotics?... How do antibiotics work?... What is antibiotic resistance?... How can I prevent antibiotic resistance?... mark for My Articles similar articles
American Family Physician
March 15, 2001
Avoiding Resistance to Antibiotics-- When Do I Need an Antibiotic? When bacteria are exposed to the same antibiotics, after a while the antibiotic can't fight the germs anymore... mark for My Articles similar articles
Chemistry World
July 15, 2010
Matt Wilkinson
Biotechs plot path of least resistance Biopharmaceutical companies are moving into antibiotics, and filling the void left by big pharma. mark for My Articles similar articles
The Motley Fool
July 3, 2008
Brian Lawler
A Cubist Masterstroke Cubist Pharmaceuticals, until now a one-drug wonder, becomes a marketer of two compounds. mark for My Articles similar articles
American Family Physician
December 15, 2000
Antibiotics: When They Can and Can't Help Antibiotics are strong medicines that can stop some infections and save lives. When they aren't used the right way, antibiotics can cause more harm than good. You can protect yourself and your family by knowing when you should use antibiotics and when you should avoid them... mark for My Articles similar articles
American Family Physician
October 1, 2004
Antibiotics: When They Can and Can't Help An overview on how antibiotic therapy comes into play in the treatment of the flu and colds. mark for My Articles similar articles
American Family Physician
October 1, 2006
Antibiotics: When They Can and Can't Help What are antibiotics?... Do antibiotics always work?... What is bacterial resistance?... What can I do to help myself?... etc. mark for My Articles similar articles
The Motley Fool
January 13, 2004
David Nierengarten
Vicuron's Booster Shot With a new "super-tough" antibiotic, Vicuron's stock is super high. mark for My Articles similar articles
American Family Physician
March 15, 2001
Thomas Hooton & Stuart Levy
Antimicrobial Resistance: A Plan of Action for Community Practice Antibiotic resistance was once confined primarily to hospitals but is becoming increasingly prevalent in family practice settings, making daily therapeutic decisions more challenging. mark for My Articles similar articles
Chemistry World
December 11, 2014
Merck to buy antibiotics specialist Cubist Hours after the deal was announced, a US District Court invalidated several key patents for Cubist's top seller, Cubicin (daptomycin). mark for My Articles similar articles
The Motley Fool
January 16, 2008
Brian Lawler
Better Safe Than Sorry at Theravance Pharmaceutical company Theravance is raising cash in advance of an FDA hearing. Investors, take note. mark for My Articles similar articles
The Motley Fool
January 3, 2008
Brian Orelli
A Super Superbug Testing Market Becton, Dickinson gets FDA approval of its quick blood test for MRSA, the so-called superbug. mark for My Articles similar articles
Chemistry World
March 13, 2013
Ned Stafford
Antibiotic resistance is a 'ticking time bomb' Global research efforts to develop new antibiotics need to be accelerated urgently, the UK government's chief medical officer has warned. She adds that that new drugs are desperately needed to fight the 'catastrophic threat' of growing antimicrobial resistance. mark for My Articles similar articles
Mother Jones
December 2000
Edwin Dobb
Growing Resistance Is agribusiness squandering one of medicine's most potent weapons? mark for My Articles similar articles
AskMen.com
Jacob Franek
Superbugs So long as antibiotic use remains widespread and excessive, superbug bacteria will be here with us. Read on about some of the most common North American superbugs. mark for My Articles similar articles
Chemistry World
January 30, 2015
Rebecca Trager
Billion dollar package unveiled to fight antibiotic resistance President Obama has made a huge investment in the fight against antibiotic resistant bacteria mark for My Articles similar articles
Chemistry World
May 6, 2014
Andy Extance
WHO raises alarm on deadly bacteria The World Health Organization has warned antibiotic resistant bacteria could bring a nightmarish future, where seemingly trivial scrapes turn lethal, and currently routine operations become too risky to contemplate. mark for My Articles similar articles
Chemistry World
October 29, 2015
Anthony King
Poor diagnostics hinder battle against antibiotic resistance The tools used to diagnose bacterial infections have barely improved since the 1940s. mark for My Articles similar articles
The Motley Fool
April 6, 2011
Brian Orelli
Killing Bacteria With the Help of a Friend Optimer Pharmaceuticals has signed up Cubist Pharmaceuticals as a marketing partner for at least the next two years. mark for My Articles similar articles
Chemistry World
July 8, 2014
Anthony King
Call for new models to pay for antibiotics Governments will need to think seriously about changing the way they pay for the drugs. That's the conclusion of a report from the UK House of Commons science and technology committee. mark for My Articles similar articles
American Journal of Nursing
June 2008
Hart et al.
Acute Respiratory Infections and Antimicrobial Resistance It is important that nurses understand antimicrobial resistance and learn how to help patients, family members, and friends manage acute respiratory infections appropriately. mark for My Articles similar articles
Nursing
March 2010
Delahanty & Myers
3 bad bugs Acinetobacter baumannii, Panton-Valentine leukocidin positive methicillin-resistant Staphylococcus aureus, and infections that develop as a result of antimicrobial therapy, such as Clostridium difficile. mark for My Articles similar articles
American Family Physician
September 15, 2001
Richard Colgan & John H. Powers
Appropriate Antimicrobial Prescribing: Approaches that Limit Antibiotic Resistance Physicians should be familiar with the clinical situations in which they should provide antibiotics and those in which they may safely be withheld... mark for My Articles similar articles
Fast Company
May 2009
Elizabeth Svoboda
Biotechs Wage War on Superbugs With antibiotic resistance on the rise, three biotechs are developing new ways to wage war on superbugs. mark for My Articles similar articles
Managed Care
June 2004
Jack McCain
Health Plans Respond as Microbes Develop Resistance Techniques Managed care is having some success discouraging practices that promote the development of "superbugs." mark for My Articles similar articles
IEEE Spectrum
February 2009
Monica Heger
Computer-Designed Drugs Could Thwart Antibiotic-Resistant Bacteria Researchers use computer algorithms to tweak enzymes that make antibiotics mark for My Articles similar articles
Chemistry World
May 19, 2015
Anthony King
Roadmap to reward pharma for creating new antibiotics unveiled Pharma firms need better incentives to create novel antibiotics to head off an 'apocalyptic scenario' where commonplace infections become deadly once more. mark for My Articles similar articles
Chemistry World
December 16, 2014
Anthony King
Antimicrobial resistance will kill 300 million by 2050 without action A new report looks to a future where drug resistance is not tackled between now and 2050. mark for My Articles similar articles
American Family Physician
February 15, 2002
Paul W. Ament
Linezolid Its role in the treatment of gram-positive, drug-resistant bacterial infections... mark for My Articles similar articles
The Motley Fool
December 31, 2009
Brian Orelli
The FDA (Still) Hates Antibiotic Makers Johnson & Johnson and Basilea are the agency's latest victims. mark for My Articles similar articles
Nutrition Action Healthletter
November 1999
Michael F. Jacobson
Fighting Superbugs For more than 30 years, doctors have used the antibiotic vancomycin when all others have failed. Now vancomycin itself is starting to fail, and its successor, synercid, is already encountering resistant germs. A change in U.S. agricultural policy may be able to stem that process... mark for My Articles similar articles
Chemistry World
September 19, 2008
John Bonner
Filling the antibiotic gap Resistance to currently available antibacterial drugs is causing growing concern among doctors who find themselves unable to treat common infections mark for My Articles similar articles
The Motley Fool
May 25, 2011
Brian Orelli
Optimer's Upcoming FDA Decision: Memorable or Memorial? We'll know on Memorial Day, plus or minus a few days. mark for My Articles similar articles
Chemistry World
April 27, 2011
Carol Stanier
Drug cocktails greater than the sum of their parts Canadian scientists have shown that combining an antibiotic that is past its prime with other drugs can give it a new lease of life. mark for My Articles similar articles
Chemistry World
January 8, 2015
Matthew Gunther
New antibiotic could treat infection while dodging resistance problems A new antibiotic that can kill life-threatening bacteria -- without them appearing to be able to develop resistance to the drug -- has been discovered by a team of scientists. mark for My Articles similar articles
Managed Care
April 2000
Tim Olsen
Physician, Tarnish Not Thine Image Doctors who use the news media to criticize others, rather than initiate a constructive dialog about difficult issues such as antibiotic resistance, help erode the profession's influence. mark for My Articles similar articles
American Family Physician
December 15, 2005
Bamberger & Boyd
Management of Staphylococcus aureus Infections Because of high incidence, morbidity, and antimicrobial resistance, Staphylococcus aureus infections are a growing concern for family physicians. mark for My Articles similar articles